您的当前位置:首页 > 行业数据 > 国内获批的血小板疾病药物较多,靶点以TPOR为主
图片属性
图片格式:PNG 图片大小:330KB 图片尺寸:2327*1514
同报告图片
 / 4
国内获批的血小板疾病药物较多,靶点以TPOR为主_第1页
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
国内获批的血小板疾病药物较多,靶点以TPOR为主_第2页
国内获批的血小板疾病药物较多,靶点以TPOR为主_第3页
国内获批的血小板疾病药物较多,靶点以TPOR为主_第4页
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
国内获批的血小板疾病药物较多,靶点以TPOR为主_第5页
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
所属报告: 三生制药-港股公司首次覆盖报告:核心品种持续发力多款创新药进入收获期-250327(29页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠